Christopher Gerner

9.8k total citations · 1 hit paper
227 papers, 7.4k citations indexed

About

Christopher Gerner is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Christopher Gerner has authored 227 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Molecular Biology, 38 papers in Immunology and 37 papers in Oncology. Recurrent topics in Christopher Gerner's work include Advanced Proteomics Techniques and Applications (26 papers), Metabolomics and Mass Spectrometry Studies (17 papers) and Cancer, Hypoxia, and Metabolism (17 papers). Christopher Gerner is often cited by papers focused on Advanced Proteomics Techniques and Applications (26 papers), Metabolomics and Mass Spectrometry Studies (17 papers) and Cancer, Hypoxia, and Metabolism (17 papers). Christopher Gerner collaborates with scholars based in Austria, Germany and United Kingdom. Christopher Gerner's co-authors include Samuel M. Meier, Andrea Bileck, Astrid Slany, Rolf Schulte‐Hermann, Bernhard K. Keppler, Walter Berger, Georg Sauermann, Séamus J. Martin, Wilfried Bursch and J. Walsh and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Chemical Society Reviews.

In The Last Decade

Christopher Gerner

224 papers receiving 7.3k citations

Hit Papers

Structure–activity relationships for ruthenium and osmium... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development
    2017 368 citations Samuel M. Meier, Christopher Gerner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Gerner Austria 45 3.7k 1.4k 904 865 670 227 7.4k
Jakob Troppmair Austria 50 4.4k 1.2× 1.0k 0.7× 973 1.1× 705 0.8× 458 0.7× 157 7.9k
Andrew A. Amoscato United States 46 4.9k 1.3× 746 0.5× 1.4k 1.6× 821 0.9× 591 0.9× 106 7.9k
Xiaodong Wang China 44 4.7k 1.3× 476 0.3× 496 0.5× 1.4k 1.6× 608 0.9× 308 8.7k
Christian Ihling Germany 45 4.0k 1.1× 672 0.5× 882 1.0× 620 0.7× 1.4k 2.1× 187 7.7k
Gerry R. Boss United States 51 4.1k 1.1× 918 0.7× 549 0.6× 557 0.6× 371 0.6× 216 8.1k
Yuqin Wang China 47 3.8k 1.0× 1.3k 0.9× 704 0.8× 500 0.6× 767 1.1× 271 7.4k
Gaetano Cairo Italy 52 3.8k 1.0× 1.8k 1.3× 709 0.8× 1.0k 1.2× 152 0.2× 140 10.8k
Peter de Witte Belgium 54 3.0k 0.8× 837 0.6× 773 0.9× 706 0.8× 171 0.3× 279 9.5k
Yuxin Yin China 48 6.6k 1.8× 2.8k 2.0× 881 1.0× 1.8k 2.0× 271 0.4× 202 9.3k
Svetlana Lutsenko United States 59 4.9k 1.3× 3.3k 2.4× 431 0.5× 1.2k 1.4× 675 1.0× 149 14.0k

Countries citing papers authored by Christopher Gerner

Since Specialization
Citations

This map shows the geographic impact of Christopher Gerner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Gerner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Gerner more than expected).

Fields of papers citing papers by Christopher Gerner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Gerner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Gerner. The network helps show where Christopher Gerner may publish in the future.

Co-authorship network of co-authors of Christopher Gerner

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Gerner. A scholar is included among the top collaborators of Christopher Gerner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Gerner. Christopher Gerner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bolliger, Michael, Michael Wolf, Birgit Reiter, et al.. (2025). Mass spectrometry-based analysis of eccrine sweat supports predictive, preventive and personalised medicine in a cohort of breast cancer patients in Austria. The EPMA Journal. 16(1). 165–182. 1 indexed citations
3.
Meier, Samuel M., Bernhard K. Keppler, Gunda Koellensperger, et al.. (2025). Mechanical cues rewire lipid metabolism and support chemoresistance in epithelial ovarian cancer cell lines OVCAR3 and SKOV3. Cell Communication and Signaling. 23(1). 193–193. 4 indexed citations
4.
Harrer, Dennis Christoph, Florian Lüke, Tobias Pukrop, et al.. (2024). Peroxisome proliferator-activated receptorα/γ agonist pioglitazone for rescuing relapsed or refractory neoplasias by unlocking phenotypic plasticity. Frontiers in Oncology. 13. 1289222–1289222. 3 indexed citations
5.
Kerschbaum, Hubert, et al.. (2024). Lipid-nanoparticle-induced vacuolization in microglia. Communications Biology. 7(1). 1558–1558.
6.
Slany, Astrid, Christine Pirker, Johanna C. Mader, et al.. (2023). Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin. Journal of Experimental & Clinical Cancer Research. 42(1). 27–27. 13 indexed citations
7.
Schmidt, Lukas, Martin Schreiber, Christine Pirker, et al.. (2023). Aberrant DNA Methylation, Expression, and Occurrence of Transcript Variants of the ABC Transporter ABCA7 in Breast Cancer. Cells. 12(11). 1462–1462. 6 indexed citations
8.
Slany, Astrid, Christine Pirker, Johanna C. Mader, et al.. (2023). Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells. Cells. 12(15). 2006–2006. 2 indexed citations
9.
Cseh, Klaudia, Michaela Hejl, Benjamin Neuditschko, et al.. (2022). Highly Cytotoxic Molybdenocenes with Strong Metabolic Effects Inhibit Tumour Growth in Mice. Chemistry - A European Journal. 29(4). e202202648–e202202648. 3 indexed citations
10.
Kovarík, J, Andrea Bileck, Samuel M. Meier, et al.. (2022). A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. iScience. 26(1). 105717–105717. 55 indexed citations
11.
Weibel, Janine, Hans‐Peter Landolt, Francesco Santini, et al.. (2021). Daily Caffeine Intake Induces Concentration-Dependent Medial Temporal Plasticity in Humans: A Multimodal Double-Blind Randomized Controlled Trial. Cerebral Cortex. 31(6). 3096–3106. 22 indexed citations
12.
Meier, Samuel M., Benjamin Neuditschko, Marlene C. Gerner, et al.. (2020). An Organometallic Gold(I) Bis‐N‐Heterocyclic Carbene Complex with Multimodal Activity in Ovarian Cancer Cells. Chemistry - A European Journal. 26(67). 15528–15537. 51 indexed citations
13.
Kulterer, Oana C., Carsten T. Herz, Alexander Haug, et al.. (2020). The Presence of Active Brown Adipose Tissue Determines Cold-Induced Energy Expenditure and Oxylipin Profiles in Humans. The Journal of Clinical Endocrinology & Metabolism. 105(7). 2203–2216. 47 indexed citations
14.
Andreatta, Gabriele, Caroline Broyart, Vitaly V. Kozin, et al.. (2019). Corazonin signaling integrates energy homeostasis and lunar phase to regulate aspects of growth and sexual maturation in Platynereis. Proceedings of the National Academy of Sciences. 117(2). 1097–1106. 26 indexed citations
15.
Bekos, Christine, Besnik Muqaku, Sabine Dekan, et al.. (2019). NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer—An Integrative Multi-Omics Approach. Cancers. 11(5). 698–698. 30 indexed citations
16.
Burbridge, Emma, Miguel Cavadas, Graeme P. Sullivan, et al.. (2018). iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE. eLife. 7. 64 indexed citations
17.
18.
Schwarzer, Rémy, Danijel Kivaranovic, Mattias Mandorfer, et al.. (2017). Randomised clinical study: the effects of oral taurine 6g/day vs placebo on portal hypertension. Alimentary Pharmacology & Therapeutics. 47(1). 86–94. 36 indexed citations
19.
Bachmayr-Heyda, Anna, Stefanie Aust, Katharina Auer, et al.. (2016). Integrative Systemic and Local Metabolomics with Impact on Survival in High-Grade Serous Ovarian Cancer. Clinical Cancer Research. 23(8). 2081–2092. 54 indexed citations
20.
Paulitschke, Verena, Walter Berger, Bernhard Knapp, et al.. (2015). Vemurafenib Resistance Signature by Proteome Analysis Offers New Strategies and Rational Therapeutic Concepts. Molecular Cancer Therapeutics. 14(3). 757–768. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jakob Troppmair Breakdown of academic impact, for papers by Andrew A. Amoscato Breakdown of academic impact, for papers by Xiaodong Wang Breakdown of academic impact, for papers by Christian Ihling Breakdown of academic impact, for papers by Gerry R. Boss Breakdown of academic impact, for papers by Yuqin Wang Breakdown of academic impact, for papers by Gaetano Cairo Breakdown of academic impact, for papers by Peter de Witte Breakdown of academic impact, for papers by Yuxin Yin Breakdown of academic impact, for papers by Svetlana Lutsenko
Rankless by CCL
2026